We are a specialty pharmaceutical company focused on advancing treatments in dermatology.  Founded by dermatology professionals with a long and successful heritage caring for the skin, Elorac is uniquely positioned to be responsive to the needs of the dermatology community.

Our dedication to the science of dermatology and needs of patients drives our discovery, development and commercialization process.  We are passionate about finding novel solutions for the treatment of various skin conditions that affect millions of people both physically and with many in their quality of life.
 
Our mission is clear, improve lives by improving skin.

FDA grants Orphan Drug Designation to Elorac for naloxone lotion for topical treatment of pruritus accompanying cutaneous t-cell lymphoma (CTCL, also known as mycosis fungoides).  (See News.)